ISSN: 2573-4555

Medicina Tradicional y Naturopatía Clínica

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice de fuentes CAS (CASSI)
  • Google Académico
  • sherpa romeo
  • Abrir puerta J
  • Revista GenámicaBuscar
  • Búsqueda de referencia
  • Directorio de indexación de revistas de investigación (DRJI)
  • Universidad Hamdard
  • EBSCO AZ
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • ICMJE
Comparte esta página

Abstracto

A Review on Herbal and Probiotic Therapeutic Approach for Mild and Moderate COVID-19

Richard Bradley

Objectives: The coronavirus infection 2019 (COVID-19) widespread has driven to noteworthy dreariness and mortality. In spite of the fact that COVID-19 immunization is accessible, helpful alternatives are still required. The objective of the show composition is to report on a treatment methodology utilized in a naturopathic therapeutic hone for gentle and direct COVID-19.

Design: A review chart audit was conducted of 30 continuous patients analyzed with gentle and direct COVID-19 who were given multi-nutrient, home grown, and probiotic treatment in a rustic, out-patient, naturopathic essential care setting.

Conclusions: In this review chart audit, a multi-nutrient, home grown, and probiotic helpful approach for gentle and direct COVID-19 showed up to be well-tolerated. Delay in looking for treatment after side effect onset, as well as more side effects at introduction, were connected with a longer term of sickness. This treatment procedure may have clinical advantage, justifying planned clinical trials with affirmed COVID-19 cases.